Zithronour 200 Oral Suspension Mango contains Azithromycin 200mg/5ml, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections such as community-acquired pneumonia, acute bacterial sinusitis, pharyngitis, and tonsillitis, as well as skin and soft tissue infections, and uncomplicated urogenital infections caused by susceptible strains of bacteria. Azithromycin exerts its antibacterial action by binding to the 50S ribosomal subunit of susceptible bacteria, inhibiting protein synthesis and thereby preventing bacterial growth. The mango-flavored oral suspension formulation facilitates ease of administration, especially in pediatric and geriatric patients who may have difficulty swallowing tablets. Dosage and duration of therapy should be determined based on the type and severity of infection, as well as patient-specific factors including age and renal function. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Caution is advised in patients with known hypersensitivity to macrolides or a history of liver dysfunction. Concomitant use with other medications metabolized by the cytochrome P450 system should be monitored to avoid potential drug interactions. Zithronour 200 Oral Suspension Mango should be used under medical supervision to ensure optimal therapeutic outcomes and minimize resistance development.